Vor Biopharma Inc (VOR) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vor Biopharma Inc   (NASDAQ: VOR)


Vor Biopharma Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vor Biopharma Inc's ROI in the third quarter of 2026?
Vor Biopharma Inc achieved a return on average invested assets (ROI) of 293.36 % in its third quarter of 2026, this is above VOR's average return on investment of -226.3%.
Vor Biopharma Inc invested over the 12 months ending in its third quarter of 2026 $461 million

Despite the deterioration in its net income, company has improved ROI compared to the second quarter of 2026.

Within the Healthcare sector 4 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3528 to 4350.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 251.5 % 228.79 % 173.8 % 65.47 % -7.19 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 460 456 491 439 157
Return On Investment (TTM) 293.36 % 162.71 % -286.34 % -331.5 % -1865.88 %
VOR's Overall Ranking # 4350 # 3528 # 3734 # 3765 #
Seq. Investment Change TTM 19.61 % 25.1 % 46.89 % 59.92 % 11.88 %
Seq. Net Income Change TTM 115.64 % - - - -
Net Income (TTM) in Millions 1,354 628 -883 -696 -2,450

VOR Company Profile >> Back to VOR Roi Comparisons >> See Annual VOR Return On Investment



Return On Investment VOR's Ranking
Within: No.
Industry # 1
Sector # 5
Overall # 4350

Return On Investment Statistics
High Average Low
162.71 %
-226.3 %
-1865.88 %
(Jun 30 2026)   (Sep 30 2025)







Financial Statements
Vor Biopharma Inc's III. Quarter Investments $ 460 Millions VOR's Balance sheet
Vor Biopharma Inc's III. Quarter Income $ -87 Millions Quarterly VOR's Income Statement
VOR's Income by Division See VOR's Income by Division


VOR Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 439 124 183 286 232
Y / Y Investment Growth 253.2 % -31.92 % -36.23 % 23.15 % -
Net Income in Millions -696 -117 -118 -92 -69
Y / Y Net Income Growth - - - - -
Annual Return On Investment -158.55 % -94.07 % -64.56 % -32.17 % -29.64 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VOR's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VOR's Competitors
Subscribers only: Roi for Vor Biopharma Inc's Suppliers
Subscribers only: Return On Investment for VOR's Customers

Other Ratios
VOR's Roa VOR's Inventory Turnover Ratio VOR's Growth Rates VOR's Dividend Statistics
VOR's Profitability Ratios VOR's Asset Turnover Ratio VOR's Dividend Growth
VOR's Roe VOR's Valuation Ratios VOR's Financial Strength Ratios VOR's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Stablecoin Development Corporation  428.88 %
Vor Biopharma Inc   293.36 %
Indivior Pharmaceuticals Inc   108.22 %
Exelixis Inc   75.01 %
Ironwood Pharmaceuticals inc   68.68 %
Rigel Pharmaceuticals Inc  68.50 %
Alnylam Pharmaceuticals Inc   63.14 %

Date modified: 2026-10-31T10:03:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.